Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Clinical Endocrinology|November 1, 1993
Leucine metabolism in patients with Cushing's syndrome before and after successful treatmentS B Bowes, J J Benn, I N Scobie, et al.Diabetologia|August 5, 2003
The effects of a specific growth hormone antagonist on overnight insulin requirements and insulin sensitivity in young adults with Type 1 diabetes mellitusR M Williams, R Amin, F Shojaee-Moradie, et al.Diabetes, Obesity & Metabolism|January 13, 2015
Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetesR A Herring, F Shojaee-Moradie, A M Umpleby, et al.Clinical Endocrinology|April 1, 1991
Glucose metabolism in patients with Cushing's syndromeS B Bowes, J J Benn, I N Scobie, et al.Journal of Mass Spectrometry : JMS|September 1, 1996
Quantitative measurement of 3-O-methyl-D-glucose by gas chromatography-mass spectrometry as a measure of glucose transport in vivoF Shojaee-Moradie, N C Jackson, R H Jones, et al.The American Journal of Physiology|March 10, 1999
A surrogate measure of whole body leucine transport across the cell membraneR Hovorka, P V Carroll, I J Gowrie, et al.The Journal of Clinical Endocrinology and Metabolism|November 3, 2005
Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletesM L Healy, J Gibney, C Pentecost, et al.Diabetologia|August 27, 2009
Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetesF Smeeton, F Shojaee Moradie, R H Jones, et al.Diabetologia|February 25, 2005
Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin detemir and NPH insulin with a 16-h euglycaemic clampS V M Hordern, J E Wright, A M Umpleby, et al.American Journal of Physiology. Endocrinology and Metabolism|February 9, 2000
Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patientsN C Jackson, P V Carroll, D L Russell-Jones, et al.Pageof 8